[1] [1] Fanizza J, Bencardino S, Allocca M, et al. Inflammatory bowel disease and colorectal cancer[J]. Cancers (Basel), 2024, 16(17): 2943.

[3] [3] Bopanna S, Ananthakrishnan AN, Kedia S, et al. Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2017, 2(4): 269-276.

[5] [5] Chen L, Xu N, Gou D, et al. TRPM8 overexpression suppresses hepatocellular carcinoma progression and improves survival by modulating the RTP3/STAT3 pathway[J]. Cancer Med, 2024, 13(19): e70109.

[6] [6] Sheng K, Sang L, Ge H. TRPM8 knockdown relieved inflammatory response and cell apoptosis in pneumonia model induced by Streptococcus pneumoniaein vitro[J]. Cell Mol Biol (Noisy-le-grand), 2023, 69(15): 198-203.

[11] [11] Shah SC, Itzkowitz SH. Colorectal cancer in inflammatory bowel disease: mechanisms and management[J]. Gastroenterology, 2022, 162(3): 715-730. e3.

[12] [12] Zhang W, Qiao XY, Li Q, et al. Comprehensive pan-cancer analysis of TRPM8 in tumor metabolism and immune escape[J]. Front Oncol, 2022, 12: 914060.

[13] [13] Liu JJ, Li LZ, Xu P. Upregulation of TRPM8 can promote the colon cancer liver metastasis through mediating Akt/GSK-3 signal pathway[J]. Biotechnol Appl Biochem, 2022, 69(1): 230-239.

[14] [14] Kong N, Li W, Zhang J, et al. TRPM8 as a potential biomarker and therapeutic target for gastric cancer identified by a combination of text mining and RNA sequencing[J]. Curr Gene Ther, 2023, 23(5): 391-399.